ID   ZEC-127
AC   CVCL_VT84
DR   CCRID; 4201PAT-CCTCC00886
DR   Wikidata; Q98136463
RX   Patent=CN106190981A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201685.
CC   Population: Chinese.
CC   Doubling time: ~60 hours (Patent=CN106190981A).
ST   Source(s): Patent=CN106190981A
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 19
ST   D13S317: 8
ST   D16S539: 9,12
ST   D18S51: 16
ST   D19S433: 15.2
ST   D21S11: 29
ST   D2S1338: 18,25
ST   D3S1358: 15
ST   D5S818: 9,12
ST   D6S1043: 18,20
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 19
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 14
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 8
//
RX   Patent=CN106190981A;
RA   Su D., Mao W.-M., Chen Q.-X., Ying L.-S., Wu J.-Z.;
RT   "Esophagus cancer cell line and application thereof.";
RL   Patent number CN106190981A, 07-Dec-2016.
//